Diagnosis and progression of ALS

Neurology

Volumn 48, Issue 4 SUPPL. 4, 1997, Pages

  Mitsumoto, Hiroshi ^a  

^a LERNER RESEARCH INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

RILUZOLE;

AMYOTROPHIC LATERAL SCLEROSIS; CLINICAL FEATURE; COMPUTER ASSISTED TOMOGRAPHY; CONFERENCE PAPER; DEGENERATIVE DISEASE; DIAGNOSTIC IMAGING; DISEASE COURSE; ELECTROMYOGRAPHY; ELECTROPHYSIOLOGY; MORTALITY; MOTOR NEURON DISEASE; MYELOGRAPHY; NEUROLOGIC EXAMINATION; NEUROPATHOLOGY; NUCLEAR MAGNETIC RESONANCE IMAGING; ONSET AGE; PRIORITY JOURNAL; PROGNOSIS; RADIOGRAPHY;

EID: 0030898560     PISSN: 00283878     EISSN: None     Source Type: Journal    
DOI: 10.1212/wnl.48.4_suppl_4.2s     Document Type: Conference Paper

References (35)

1. Lee RJJ, Annegers JF, Appel SH. Prognosis of amyotrophic lateral sclerosis and the effect of referral selection. J Neurol Sci 1995;132:207-215.
2. Mitsumoto H. Classification and clinical features of amyotrophic lateral sclerosis. In: Mitsumoto H, Norris FH, eds. Amyotrophic lateral sclerosis: a comprehensive guide to management. New York: Demos Publications, 1994:1-19.
3. Haverkamp LJ, Appel V, Appel SH. Natural history of amyotrophic lateral sclerosis in a database population. Validation of a scoring system and a model for survival prediction. Brain 1995;118:707-719.
4. Rosen AD. Amyotrophic lateral sclerosis. Clinical features and prognosis. Arch Neurol 1978;35:638-642.
5. Charcot JM. De la sclérose latérale amyotrophique. Prog Med 1874;2:325-327, 341-342, 453-455.
6. Mulder DW, Kurland LT, Offord KP, Beard CM. Familial adult motor neuron disease: amyotrophic lateral sclerosis. Neurology 1986;36:511-517.
7. Siddique T, Nijhawan D, Hentati A. Molecular genetic basis of familial ALS. Neurology 1996;47(suppl 2):S27-S35.
8. Belsh JM, Schiffman PL. Misdiagnosis in patients with amyotrophic lateral sclerosis. Arch Intern Med 1990;150:2301-2305.
9. Norris FH. Amyotrophic lateral sclerosis: the clinical disorder. In: Smith RA, ed. Handbook of amyotrophic lateral sclerosis. New York: Marcel Dekker, 1992:3-38.
10. Tyler HR, Shefner J. Amyotrophic lateral sclerosis. In: Vinken PJ, Bruyn GW, Klawans HL, eds. Diseases of the motor system. New York: Elsevier Science Publishing, 1991:169-215.
11. Belsh JM. Clinical presentation and course of ALS. In: Belsh JM, Schiffman PL, eds. Amyotrophic lateral sclerosis: diagnosis and management. Armonk, NY: Futura Publishing, 1996: 47-83.
12. Munsat TL. The natural history of amyotrophic lateral sclerosis. In: Smith RA, ed. Handbook of amyotrophic lateral sclerosis. New York: Marcel Dekker, 1992:65-75.
13. Hudson AJ. Amyotrophic lateral sclerosis and its association with dementia and other neurological disorders. Brain 1981; 104:217-247.
14. Ringel SP, Murphy JR, Alderson MK, et al. The natural history of amyotrophic lateral sclerosis. Neurology 1993;43: 1316-1322.
15. Holstege G. Motoneurons and descending motor pathways. Limbic and nonlimbic components. In: Leigh PN, Swash M, eds. Motor neuron disease. London: Springer-Verlag, 1995: 259-330.
16. World Federation of Neurology Research Group on Neuromuscular Diseases. El Escorial World Federation of Neurology Criteria for the Diagnosis of Amyotrophic Lateral Sclerosis. J Neurol Sci 1994;124(suppl):96-107.
17. Belsh JM. Definition of terms, classification, and diagnostic criteria of ALS. In: Belsh JM, Schiffman PL, eds. Amyotrophic lateral sclerosis: diagnosis and management. Armonk, NY: Futura Publishing, 1996:25-45.
18. Behnia M, Kelly JJ. Role of electromyography in amyotrophic lateral sclerosis. Muscle Nerve 1991;14:1236-1241.
19. Denys EH. Electromyographic monitoring and prognostication in amyotrophic lateral sclerosis. In: Rose FC, ed. Progress in clinical neurologic trials, Vol 1. Amyotrophic lateral sclerosis. New York: Demos Publications, 1990:127-133.
20. Wilbourn AJ. Electrodiagnostic evaluation of the suspected ALS patient. In: Belsh JM, Schiffman PL, eds. Amyotrophic lateral sclerosis: diagnosis and management. Armonk, NY: Futura Publishing, 1996:163-201.
21. Mitsumoto H, Hanson MR, Chad DA. Amyotrophic lateral sclerosis. Recent advances in pathogenesis and therapeutic trials. Arch Neurol 1988;45:189-202.
22. Pinelli P, Pisano F. Electromyographic assessment in amyotrophic lateral sclerosis. In: Rose FC, ed. Progress in clinical neurologic trials, Vol 1. Amyotrophic lateral sclerosis. New York: Demos Publications, 1990:117-126.
23. Hoffman JM, Boyko OB, Davis WK. Neuroimaging studies in amyotrophic lateral sclerosis. In: Smith RA, ed. Handbook of amyotrophic lateral sclerosis. New York: Marcel Dekker, 1992:237-269.
24. Terao S-I, Sobue G, Yasuda T, Kachi T, Takahashi M, Mitsuma T. Magnetic resonance imaging of the corticospinal tracts in amyotrophic lateral sclerosis. J Neurol Sci 1995;133: 66-72.
25. Louwerse ES, Sillevis Smitt PAE, Vianney de Jong JMB. Differential diagnosis of sporadic amyotrophic lateral sclerosis, progressive spinal muscular atrophy and progressive bulbar palsy in adults. In: Vinken PJ, Bruyn GW, Klawans HL, eds. Diseases of the motor system. Elsevier Science Publishing, 1991:383-423.
26. Tandan R. Differential diagnosis of ALS, Part II. ALS-like syndromes and ALS variants. In: Belsh JM, Schiffman PL, eds. Amyotrophic lateral sclerosis: diagnosis and management. Armonk, NY: Futura Publishing, 1996:131-161.
27. Belsh JM. Differential diagnosis of ALS. Part 1. Non-motor neuron diseases and adult-onset spinal muscular atrophies. In: Belsh JM, Schiffman PL, eds. Amyotrophic lateral sclerosis: diagnosis and management. Armonk, NY: Futura Publishing, 1996:85-129.
28. Brooks BR. Natural history of ALS: symptoms, strength, pulmonary function, and disability. Neurology 1996;47(suppl 2): S71-S82.
29. Mitsumoto H, Chad D, Pioro EP. Amyotropic lateral sclerosis. Philadelphia: FA Davis (in press).
30. Louwerse ES, Bossuyt PMM, Weverling GJ, Vianney de Jong JMB. Mortality risk stratification in amyotrophic lateral sclerosis. J Neurol Sci 1995;129(suppl):27.
31. Eisen A, Schulzer M, MacNeil M, Pant B, Mak E. Duration of amyotrophic lateral sclerosis is age dependent. Muscle Nerve 1993;16:27-32.
32. ALS CNTF Treatment Study (ACTS) group. Prognostic indicators of survival in amyotrophic lateral sclerosis [abstract]. Neurology 1996;46:A208.
33. Daube JR. Electrophysiologic studies in the diagnosis and prognosis of motor neuron disease. Neurol Clin 1985;3:473-493.
34. Mitsumoto H, Schwartzman M, Levin KH, Shields RW, Wilbourn AJ. Electromyographic (EMG) changes and disease progression in ALS [abstract]. Neurology 1990(suppl 1):318.
35. Juneja T, Pericak-Vance MA, Laing NG, Dave S, Siddique T. Prognosis in familial ALS: progression and survival in patients with E100G and A4V mutations in Cu, Zn superoxide dismutase. Neurology (in press).